Procter & Gamble (PG) is back in focus after reporting Q3 FY2026 results that exceeded earnings expectations, paired with broad-based sales growth and reaffirmed guidance that kept its full-year outlook intact. See our latest analysis for Procter & Gamble. Despite Q3 earnings coming in ahead of expectations, Procter & Gamble’s recent share price momentum has softened, with the stock down almost 10% on a 90‑day share price return basis and the 1‑year total shareholder return declining about...